Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis.
Saved in:
| Title: | Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis. |
|---|---|
| Authors: | Kubesch, Alica1 (AUTHOR), Lande, Raul1 (AUTHOR), Leutgöb, Anna1 (AUTHOR), Farrag, Karima1 (AUTHOR), Dahmer, Iulia2 (AUTHOR), Stratmann-Vollrath, Katharina1 (AUTHOR), Dienethal, Antje1 (AUTHOR), Michael, Florian Alexander1 (AUTHOR), Sprinzl, Kathrin1 (AUTHOR), Zeuzem, Stefan1 (AUTHOR), Blumenstein, Irina1 (AUTHOR) blumenstein@em.uni-frankfurt.de |
| Source: | PLoS ONE. 10/24/2025, Vol. 20 Issue 10, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0334897 |
